← Back to Patent Explorer
US5122453A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for discriminating surface stained lymphocytes

Assignee: Bayer Corp
•
Filing: 1988-05-03
•
Granted: 1992-06-16
•
Expires: 2008-05-03
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A flow cytometry method for reproducibly detecting and counting a lymphocyte population of interest in a leukocyte suspension or whole blood sample in which the red cells are subsequently lysed. The suspension (or sample) is combined with a reagent comprising a primary antibody, either native, carrying an attached enzyme or biotin or other label, and a fixative reagent, in either order. Where the enzyme is not attached, an enzyme is coupled specifically to the primary antibody. The fixed suspension is reacted with a color-producing enzyme-cytochemical reagent. The suspension, now including stained and unstained fixed cells, is passed through a flow cytometer and the cells are characterized and counted on the basis of their light-scattering and light-absorbing properties.

Inventors

  • 👤 Grace E. Martin
  • 👤 Robert J. Kanter
  • 👤 Young R. Kim
  • 👤 Leonard Ornstein
  • 👤 Hudson R. Ansley

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 10:42
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/569; G01N33/56966; G01N33/56972; Y; Y10; Y10S; Y10S436/00; Y10S436/805; Y10S436/825

Claims Analysis

Total Claims: 32
Claim 1
Independent Claim 258 words
A flow cytometry method for detecting a lymphocyte population of interest in a heterogeneous whole blood cell suspension containing various classes of leukocytes, and wherein the red blood cells are lysed prior to said measurement, which method comprises: (a) first reacting said whole blood cell suspension with a first reagent comprising up to about 7.5% formaldehyde and up to about 15% sugar for up to about 10 minutes to fix and stabilize the cells in said whole blood cell suspension; (b) then incubating said fixed cell suspension of step (a) with a second reagent comprising primary antibodies specific for T lymphocyte or B lymphocyte surface antigens of said lymphocyte population of interest to form a primary antibody-labeled-fixed-lymphocyte population in said cell suspension; (c) then reacting said primary antibody-labeled-fixed-lymphocyte population of step (b) with an enzyme-ligand-conjugate wherein said ligand is specific for the immunoglobin class of said primary antibodies to form a cell suspension wherein said enzyme-ligand-conjugate is bound to said primary antibody-labeled-fixed-lymphocyte population; (d) thereafter reacting said cell-suspension of step (c) with at least one composition which reacts with said enzyme to stain said lymphocyte population of interest; (e) subsequently passing said cell-suspension of step (d) substantially one cell at a time, through a light beam while measuring light scattered and light absorbed by each cell passing therethrough; and (f) discriminating between stained and unstained cells in part on the magnitude of the light scattering and adsorption responses, whereby the stained cells indicate the presence of the lymphocyte population of interest in said heterogeneous whole blood cell suspension.
Claim 2
Dependent Claim 258 words
A flow cytometry method for detecting a lymphocyte population of interest in a heterogeneous whole blood cell suspension containing various classes of leukocytes, and wherein the red blood cells are lysed prior to said measurement, which method comprises: (a) first reacting said whole blood cell suspension with a first reagent comprising up to about 7.5% formaldehyde and up to about 15% sugar for up to about 10 minutes to fix and stabilize the cells in said whole blood cell suspension; (b) then incubating said fixed cell suspension of step (a) with a second reagent comprising primary antibodies specific for T lymphocyte or B lymphocyte surface antigens of said lymphocyte population of interest to form a primary antibody-labeled-fixed-lymphocyte population in said cell suspension; (c) then reacting said primary antibody-labeled-fixed-lymphocyte population of step (b) with an enzyme-ligand-conjugate wherein said ligand is specific for the immunoglobin class of said primary antibodies to form a cell suspension wherein said enzyme-ligand-conjugate is bound to said primary antibody-labeled-fixed-lymphocyte population; (d) thereafter reacting said cell-suspension of step (c) with at least one composition which reacts with said enzyme to stain said lymphocyte population of interest; (e) subsequently passing said cell-suspension of step (d) substantially one cell at a time, through a light beam while measuring light scattered and light absorbed by each cell passing therethrough; and (f) discriminating between stained and unstained cells in part on the magnitude of the light scattering and adsorption responses, whereby the stained cells indicate the presence of the lymphocyte population of interest in said heterogeneous whole blood cell suspension.
Claim 3
Dependent Claim 25 words
The method of claim 11 further including the step of lysing the red blood cells in said whole blood cell suspension prior to step (a).
Claim 4
Dependent Claim 24 words
The method of claim 11 further including the step of lysing the red blood cells in said whole blood cell suspension after step (a).
Claim 5
Dependent Claim 24 words
The method of claim 3 further including the step of lysing the red blood cells in said whole blood cell suspension after step (b).
Claim 6
Dependent Claim 19 words
The method of claim 4 wherein said primary antibodies of said second reagent of step (b) are monoclonal antibodies.
Claim 7
Dependent Claim 54 words
The method of claim 1 wherein said reacting step (c) includes: (c') incubating said primary antibody-labeled-fixed-lymphocyte population of step (b) with biotinylated secondary antibody specific for said primary antibody to bind to said primary antibody; and (c") thereafter reacting the cell mixture of step (c') with a second enzyme-ligand-conjugate which binds specifically to biotin.
Claim 8
Dependent Claim 13 words
The method of claim 6 wherein said biotinylated secondary antibodies are polyclonal antibodies.
Claim 9
Dependent Claim 16 words
The method of claim 6 wherein said ligand of said second enzyme ligand conjugate is avidin.
Claim 10
Dependent Claim 11 words
The method of claim 8 wherein said enzyme-avidin-conjugate is a peroxidase-avidin.
Claim 11
Dependent Claim 12 words
The method of claim 8 wherein said enzyme-avidin-conjugate is an alkaline phosphate-avidin-conjugate.
Claim 12
Dependent Claim 11 words
The method of claim 1 wherein said enzyme-ligand-conjugate comprises an avidin-biotin-enzyme-conjugate.
Claim 13
Dependent Claim 11 words
The method of claim 11 wherein said enzyme is a peroxidase.
Claim 14
Dependent Claim 12 words
The method of claim 11 wherein said enzyme is an alkaline phosphatase.
Claim 15
Dependent Claim 30 words
The method of claim 1 wherein said enzyme reacts with a chromogen, and said at least one composition contains a chromogen selected from the group consisting of 3-amino-9-ethylcarbazole and 4-chloro-1-naphthol.
Claim 16
Dependent Claim 10 words
The method of claim 1 wherein said sugar is dextrose.
Claim 17
Dependent Claim 255 words
A flow cytometry method for detecting a lymphocyte population of interest in a heterogeneous whole blood cell suspension containing various classes of leukocytes, and wherein the red blood cells are lysed prior to said measurement, which method comprises: (a) first incubating said whole blood cell suspension with a reagent comprising primary antibodies specific for T lymphocyte or a B lymphocyte surface antigens of said lymphocyte population of interest to form a primary antibody-labeled-lymphocyte population in said cell suspension; (b) then reacting said cell suspension of step (a) with a first reagent comprising up to about 7.5% formaldehyde and up to about 15% sugar for up to about 10 minutes to fix and stabilize the cells in said cell suspension; (c) then reacting said primary antibody-labeled-fixed-lymphocyte population of step (b) with an enzyme-ligand-conjugate wherein said ligand is specific for the immunoglobin class of said primary antibodies to form a cell suspension wherein said enzyme-ligand-conjugate is bound to said primary antibody-labeled-fixed-lymphocyte population; (d) thereafter reacting said cell-suspension of step (c) with at least one composition which reacts with said enzyme to stain said lymphocyte population of interest; (e) subsequently passing said cell-suspension of step (d) substantially one cell at a time, through a light beam while measuring light scattered and light absorbed by each cell passing therethrough; and (f) discriminating between stained and unstained cells in part on the magnitude of the light scattering and adsorption responses, whereby the stained cells indicate the presence of the lymphocyte population of interest in said heterogeneous whole blood cell suspension.
Claim 18
Dependent Claim 255 words
A flow cytometry method for detecting a lymphocyte population of interest in a heterogeneous whole blood cell suspension containing various classes of leukocytes, and wherein the red blood cells are lysed prior to said measurement, which method comprises: (a) first incubating said whole blood cell suspension with a reagent comprising primary antibodies specific for T lymphocyte or a B lymphocyte surface antigens of said lymphocyte population of interest to form a primary antibody-labeled-lymphocyte population in said cell suspension; (b) then reacting said cell suspension of step (a) with a first reagent comprising up to about 7.5% formaldehyde and up to about 15% sugar for up to about 10 minutes to fix and stabilize the cells in said cell suspension; (c) then reacting said primary antibody-labeled-fixed-lymphocyte population of step (b) with an enzyme-ligand-conjugate wherein said ligand is specific for the immunoglobin class of said primary antibodies to form a cell suspension wherein said enzyme-ligand-conjugate is bound to said primary antibody-labeled-fixed-lymphocyte population; (d) thereafter reacting said cell-suspension of step (c) with at least one composition which reacts with said enzyme to stain said lymphocyte population of interest; (e) subsequently passing said cell-suspension of step (d) substantially one cell at a time, through a light beam while measuring light scattered and light absorbed by each cell passing therethrough; and (f) discriminating between stained and unstained cells in part on the magnitude of the light scattering and adsorption responses, whereby the stained cells indicate the presence of the lymphocyte population of interest in said heterogeneous whole blood cell suspension.
Claim 19
Dependent Claim 25 words
The method of claim 16 further including the step of lysing the red blood cells in said whole blood cell suspension prior to step (a).
Claim 20
Dependent Claim 24 words
The method of claim 16 further including the step of lysing the red blood cells in said whole blood cell suspension after step (a).
Claim 21
Dependent Claim 24 words
The method of claim 18 further including the step of lysing the red blood cells in said whole blood cell suspension after step (b).
Claim 22
Dependent Claim 18 words
The method of claim 16 wherein said primary antibodies of said reagent of step (a) are monoclonal antibodies.
Claim 23
Dependent Claim 53 words
The method of claim 16 wherein said reacting step (c) includes: (c') incubating said primary antibody-labeled-fixed-lymphocyte population of step (b) with biotinylated secondary antibody specific for said primary antibody to bind said primary antibody; and (c") thereafter reacting the cell mixture of step (c') with a second enzyme-ligand-conjugate which binds specifically to biotin.
Claim 24
Dependent Claim 13 words
The method of claim 21 wherein said biotinylated secondary antibodies are polyclonal antibodies.
Claim 25
Dependent Claim 15 words
The method of claim 21 wherein said ligand of said enzyme ligand conjugate is avidin.
Claim 26
Dependent Claim 11 words
The method of claim 23 wherein said enzyme-avidin-conjugate is a peroxidase-avidin.
Claim 27
Dependent Claim 12 words
The method of claim 23 wherein said enzyme-avidin-conjugate is an alkaline phosphatase-avidin-conjugate.
Claim 28
Dependent Claim 11 words
The method of claim 16 wherein said enzyme-ligand-conjugate comprises an avidin-biotin-enzyme-conjugate.
Claim 29
Dependent Claim 11 words
The method of claim 24 wherein said enzyme is a peroxidase.
Claim 30
Dependent Claim 12 words
The method of claim 26 wherein said enzyme is an alkaline phosphatase.
Claim 31
Dependent Claim 30 words
The method of claim 16 wherein said enzyme reacts with a chromogen and said at least one composition comprises a chromogen selected from the group consisting of 3-amino-9-ethylcarbazole and 4-chloro-1-naphthol.
Claim 32
Dependent Claim 10 words
The method of claim 16 wherein said sugar is dextrose.

References Cited (Backward Citations)

US4228237A Cited
US4492752A Cited
US4499183A Cited
US4654312A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1995-06-16 1995-12-16 1996-06-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1999-06-16 1999-12-16 2000-06-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2003-06-16 2003-12-16 2004-06-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag